Ready-made ETF portfolios built for real investor needs. Explore now →
VanEck Pharmaceutical ETF
PPH performance and flow charts
Performance
Flows
Historic performance and flows
Data as of September 2, 2026| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | +6.34% | +14.75% | +13.56% | +32.27% | +51.27% | +65.44% |
| Flows | +$85M | +$66M | -$326M | +$191M | +$359M | +$436M |
Characteristics
The VanEck Pharmaceutical ETF is built to track the MVIS US Listed Pharmaceutical 25 Net Total Return Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.
| Management strategy | Passive |
| Strategy | Long Only |
| Provider | VanEck |
| N° of holdings | 25 |
| Replication method | Direct (Physical) |
| Asset class | Equity |
| Dividend policy | Distributing |
Trailing 12m distribution yield | Join for free |
| Inception date | December 20, 2011 |
| ESG | No |
More data and info about PPH on Trackinsight
Exposure
Data as of July 31, 2026Diversification
Total weight of top 15 holdings out of 25
Top 15 Holdings
Sectors
Countries
Similar ETFs
Trading data
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Volatility | +21.81% | +18.38% | +16.11% | +15.57% |
Max drawdown | -4.80% | -10.78% | -17.98% | -20.19% |
Max drawdown duration | 21d | 122d | 434d | 484d |
Time to recover | 15d | 64d | 215d | 315d |
Replication quality
Data as of August 31, 2026Create an account to view replication metrics
1 year cumulative return difference | |
|---|---|
| Best | Join for free |
| Worst | Join for free |
| daily return difference | |
|---|---|
| Average | Join for free |
| Worst | Join for free |
What type of ETF is PPH?
PPH is a Passive ETF that provides exposure to Equity assets. It is managed by VanEck.
What index does PPH track?
PPH tracks the MVIS US Listed Pharmaceutical 25 Net Total Return Index - USD, aiming to replicate its performance through full replication.
What does PPH invest in?
This ETF provides exposure to Pharmaceuticals Equities. It is part of the segment: Uncategorized Equities.
What is the expense ratio of PPH?
The total expense ratio (TER) of PPH is 0.36%, representing the annual fee charged by the fund manager.
When was PPH launched?
PPH was launched on December 20, 2011, marking its entry into the ETF market.
Who is the issuer of PPH?
PPH is issued by VanEck.
What is the AUM of PPH?
As of September 2, 2026, PPH manages $1.06 B, reflecting the total assets held in the fund.
How has PPH performed recently?
As of September 2, 2026, PPH delivered a return of 6.34% over the past month (1M performance), 14.75% over the past three months (3M), and 13.56% year-to-date (YTD).
What are the recent fund flows for PPH?
As of September 2, 2026, PPH has seen net flows of +$85M in the past month (1M flow) and -$326M year-to-date (YTD).
Does PPH pay dividends?
As of September 2, 2026, PPH has a trailing 12-month distribution yield of 1.88%.
How many holdings are in PPH
As of July 31, 2026, PPH holds 25 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.
How diversified is PPH?
As of July 31, 2026, PPH holds 25 securities, with 90.28% of its assets concentrated in its top 15 holdings.
What are the top holdings of PPH?
As of July 31, 2026, PPH holds a portfolio of 25 underlyings, with its largest positions including Eli Lilly & Co., Novartis AG and Merck & Co., Inc.. These top holdings play a significant role in shaping the fund’s performance and exposure.
What countries or regions does PPH invest in?
As of July 31, 2026, PPH has its largest geographic exposures in USA, United Kingdom and Switzerland.
What sectors or themes does PPH focus on?
As of July 31, 2026, PPH is primarily exposed to Healthcare.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
ETF Trends
ETF Industry KPIs August 31, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
ETF Trends
ETF Industry KPIs August 24, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
What’sTheFund
What's the Fund | Ocean Park Diversified Income ETF (DUKZ)
James St Aubin, Chief Investment Officer at Ocean Park Asset Management, discuss the DUKZ ETF, exposing investors to the whole spectrum of asset classes in the fixed income markets, through their rules-based process.
ETF Takeaway
ETF Takeaway: Ocean Park Diversified Income ETF (DUKZ)
James St Aubin, Chief Investment Officer at Ocean Park Asset Management discusses the state of fixed income markets and how their DUKZ ETF, through their rules-based process, tactically allocates to 11 sectors of fixed income through underlying ETFs.
Browse all educational columns
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
